Incorporated in 1981, Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron Tablets
Business Overview:[1][2]Company provides various therapeutic dosage combinations for Ministry of Health & Family Welfare and also for exports. In FY20, company became a Sick Industrial Company under SICA and was referred to BIFR.
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Sun Pharma.Inds. | 1668.90 | 34.69 | 400460.33 | 0.96 | 3124.95 | 2.56 | 14478.31 | 8.93 | 20.21 | 54964.01 | 30.12 | 11543.96 | 3117.95 | 5.15 | 12.97 | 0.07 |
| 2. | Divi's Lab. | 6236.00 | 66.61 | 165513.66 | 0.48 | 689.00 | 35.10 | 2715.00 | 16.12 | 20.44 | 10029.00 | 32.37 | 2485.00 | 689.00 | 10.74 | 13.53 | 0.01 |
| 3. | Torrent Pharma. | 4018.20 | 62.75 | 135955.09 | 0.80 | 591.00 | 32.49 | 3302.00 | 14.30 | 27.05 | 12248.00 | 32.60 | 2166.53 | 600.17 | 16.10 | 13.26 | 0.33 |
| 4. | Cipla | 1397.50 | 20.75 | 112878.16 | 0.93 | 1353.37 | 3.73 | 7589.44 | 7.64 | 22.72 | 28349.57 | 25.40 | 5441.14 | 1351.17 | 3.43 | 14.72 | 0.01 |
| 5. | Lupin | 2177.90 | 23.01 | 99527.00 | 0.55 | 1484.83 | 73.34 | 7047.51 | 24.23 | 21.30 | 24750.69 | 27.25 | 4324.63 | 1477.92 | 5.07 | 12.41 | 0.32 |
| 6. | Dr Reddy's Labs | 1175.50 | 17.00 | 98114.93 | 0.68 | 1336.80 | 7.28 | 8828.30 | 9.83 | 22.69 | 34310.00 | 24.64 | 5772.20 | 1347.10 | 2.72 | 12.95 | 0.16 |
| 7. | Mankind Pharma | 2175.40 | 51.37 | 89821.63 | 0.05 | 520.18 | -22.00 | 3697.16 | 20.77 | 15.98 | 13545.67 | 24.12 | 1748.55 | 511.51 | 5.87 | 8.89 | 0.55 |
| 8. | Phaarmasia | 119.45 | 104.59 | 81.58 | 0.00 | 1.74 | 371.88 | 16.55 | 179.09 | -16.47 | 33.57 | 0.89 | 0.78 | 1.74 | 7.59 | -6.00 | 0.00 |
| – | Median: 149 Co. | 392.6 | 30.0 | 1767.16 | 0.12 | 13.96 | 10.46 | 161.76 | 10.58 | 14.89 | 603.85 | 15.93 | 45.26 | 14.12 | 3.13 | 8.56 | 0.22 |
Standalone figures in ₹ crores
| Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 5.38 | 6.67 | 7.94 | 7.50 | 6.88 | 8.64 | 5.08 | 9.99 | 8.29 | 5.93 | 4.72 | 5.43 | 6.87 | 16.55 |
Expenses | 5.72 | 7.03 | 8.58 | 7.71 | 7.19 | 8.91 | 5.65 | 9.66 | 8.11 | 6.72 | 5.51 | 6.04 | 6.78 | 14.94 |
Operating Profit | -0.34 | -0.36 | -0.64 | -0.21 | -0.31 | -0.27 | -0.57 | 0.33 | 0.18 | -0.79 | -0.79 | -0.61 | 0.09 | 1.61 |
Other Income | 0.13 | 0.14 | 0.11 | 0.14 | 0.14 | 0.20 | 0.13 | 0.19 | 0.15 | 0.22 | 0.19 | 0.18 | 0.32 | 0.14 |
Profit before tax | -0.27 | -0.29 | -0.59 | -0.27 | -0.27 | -0.17 | -0.54 | 0.43 | 0.25 | -0.65 | -0.69 | -0.51 | 0.32 | 1.70 |
Tax % | 3.70% | -3.45% | 0.00% | -66.67% | 0.00% | -5.88% | 3.70% | -9.30% | -12.00% | 0.00% | 1.45% | 1.96% | 12.50% | -2.35% |
Net Profit | -0.28 | -0.29 | -0.59 | -0.09 | -0.27 | -0.16 | -0.56 | 0.47 | 0.28 | -0.64 | -0.70 | -0.53 | 0.27 | 1.74 |
EPS in Rs | -0.41 | -0.42 | -0.86 | -0.13 | -0.40 | -0.23 | -0.82 | 0.69 | 0.41 | -0.94 | -1.03 | -0.78 | 0.40 | 2.55 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 15.16 | 12.30 | 13.68 | 14.33 | 18.97 | 23.97 | 19.93 | 16.20 | 16.88 | 27.42 | 30.59 | 24.37 | 33.57 |
Expenses | 14.32 | 11.35 | 12.94 | 14.19 | 18.31 | 23.24 | 19.11 | 16.26 | 18.62 | 28.97 | 31.41 | 26.38 | 33.27 |
Operating Profit | 0.84 | 0.95 | 0.74 | 0.14 | 0.66 | 0.73 | 0.82 | -0.06 | -1.74 | -1.55 | -0.82 | -2.01 | 0.30 |
Other Income | 0.00 | 0.07 | 0.01 | 0.58 | 0.53 | 0.60 | 0.58 | 0.89 | 0.47 | 0.52 | 0.66 | 0.75 | 0.83 |
Interest | 0.02 | 0.03 | 0.01 | 0.01 | 0.04 | 0.04 | 0.04 | 0.01 | 0.00 | 0.04 | 0.04 | 0.02 | 0.04 |
Depreciation | 0.38 | 0.76 | 0.50 | 0.44 | 0.47 | 0.46 | 0.40 | 0.34 | 0.29 | 0.36 | 0.34 | 0.32 | 0.27 |
Profit before tax | 0.44 | 0.23 | 0.24 | 0.27 | 0.68 | 0.83 | 0.96 | 0.48 | -1.56 | -1.43 | -0.54 | -1.60 | 0.82 |
Net Profit | 0.35 | 0.14 | 0.04 | 0.16 | 0.57 | 0.78 | 0.54 | 0.31 | -1.55 | -1.26 | -0.52 | -1.59 | 0.78 |
EPS in Rs | 0.51 | 0.21 | 0.06 | 0.23 | 0.83 | 1.14 | 0.79 | 0.45 | -2.27 | -1.85 | -0.76 | -2.33 | 1.14 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | – |
Standalone figures in ₹ crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 | 6.83 |
Reserves | 0.62 | 6.28 | 5.04 | 4.83 | 5.20 | 5.99 | 6.58 | 6.83 | 5.23 | 3.98 | 3.47 | 1.91 | 3.91 |
Borrowings | 0.00 | 0.11 | 0.09 | 0.07 | 0.22 | 0.19 | 0.08 | 0.05 | 0.03 | 0.27 | 0.14 | 0.01 | 0.00 |
Other Liabilities | 5.91 | 6.17 | 6.74 | 7.81 | 9.67 | 20.25 | 20.11 | 8.20 | 9.12 | 17.34 | 21.01 | 12.81 | 33.52 |
Total Liabilities | 13.36 | 19.39 | 18.70 | 19.54 | 21.92 | 33.26 | 33.60 | 21.91 | 21.21 | 28.42 | 31.45 | 21.56 | 44.26 |
Fixed Assets | 10.51 | 15.61 | 14.11 | 13.74 | 14.18 | 13.80 | 13.40 | 13.06 | 12.76 | 12.79 | 12.48 | 12.32 | 12.29 |
Gross Block | 29.71 | 35.50 | 34.50 | 14.18 | 15.08 | 15.12 | 15.12 | 15.12 | 15.12 | 15.40 | 15.53 | 15.70 | – |
Accumulated Depreciation | 19.20 | 19.89 | 20.38 | 0.44 | 0.91 | 1.33 | 1.72 | 2.07 | 2.36 | 2.61 | 3.05 | 3.37 | – |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Assets | 2.85 | 3.78 | 4.59 | 5.80 | 7.74 | 19.46 | 20.20 | 8.85 | 8.45 | 15.63 | 18.97 | 9.24 | 31.97 |
Total Assets | 13.36 | 19.39 | 18.70 | 19.54 | 21.92 | 33.26 | 33.60 | 21.91 | 21.21 | 28.42 | 31.45 | 21.56 | 44.26 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | 0.16 | 0.48 | 0.28 | -0.08 | 0.88 | 0.06 | 0.08 | 0.25 | -0.18 | 0.65 | 0.11 | 0.00 |
Cash from Investing Activity | -0.17 | -0.34 | -0.28 | -0.18 | -0.92 | -0.10 | 0.00 | 0.00 | 0.01 | -0.01 | 0.00 | -0.12 |
Cash from Financing Activity | 0.00 | 0.12 | 0.16 | -0.02 | 0.08 | 0.04 | -0.11 | -0.02 | 0.00 | -0.16 | -0.16 | -0.15 |
Net Cash Flow | -0.01 | 0.26 | 0.17 | -0.29 | 0.04 | 0.00 | -0.03 | 0.23 | -0.17 | 0.48 | -0.06 | -0.27 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 47.67 | 47.78 | 77.64 | 90.68 | 72.92 | 179.07 | 225.63 | 96.21 | 68.98 | 99.97 | 96.05 | 46.58 |
Inventory Days | 13.98 | 80.49 | 11.77 | 55.86 | 43.40 | 134.51 | 124.67 | 65.84 | 111.66 | 103.36 | 126.07 | 57.39 |
Days Payable | 57.90 | 184.68 | 216.27 | 292.87 | 249.28 | 403.08 | 374.43 | 166.48 | 214.10 | 268.79 | 297.81 | 224.33 |
Cash Conversion Cycle | 3.74 | -56.42 | -126.86 | -146.33 | -132.96 | -89.49 | -24.13 | -4.43 | -33.46 | -65.47 | -75.69 | -120.35 |
Working Capital Days | -71.75 | -79.23 | -64.04 | -43.05 | -33.67 | -12.79 | 6.78 | 7.66 | -17.30 | -39.00 | -42.60 | -71.29 |
ROCE % | 6.15% | 2.52% | 1.99% | 2.36% | 6.01% | 6.65% | 7.55% | 3.60% | -12.09% | -12.00% | -4.65% | -16.47% |
Direct from BSE filings, auto-summarised
External media mentions & references
No credit ratings.
No concalls.
Stock Analysis
Phaarmasia Ltd. is an Indian company incorporated in 1981, primarily engaged in the manufacturing and marketing of cosmetics and pharmaceuticals, including Oral Contraceptive Pills (OCP).
Recent Q2 FY26 and H1 FY26 results indicate a turnaround with significant YoY revenue growth and positive net profit. The strategic sale of a significant property in Hyderabad for at least ₹25 crore is also a key event expected to bolster the balance sheet and fund business needs.
Currently no data available for Order Book.
The company was previously identified as a Sick Industrial Company under SICA and referred to the Board for Industrial and Financial Reconstruction (BIFR).
Currently no data available for Key Dates To Watch.
Corporate Announcements
